Phase I investigation of recombinant anti-human vascular endothelial growth factor antibody in patients with advanced cancer

MLA

Leif Håkansson, et al. “Phase I Investigation of Recombinant Anti-Human Vascular Endothelial Growth Factor Antibody in Patients with Advanced Cancer.” European Journal of Cancer, vol. 41, Mar. 2005, pp. 555–63. EBSCOhost, https://doi.org/10.1016/j.ejca.2004.11.021.

APA

Leif Håkansson, Meina Tang, Linda Wauk, C Mulatero, Malcolm R Ranson, John Wagstaff, Sandrine Marreaud, Lynn Broughton, Frederic Lehmann, Gordon C Jayson, D. Levitt, Manfred Herold, Alan Jackson, Jeremy A L Lawrance, Gerard Groenewegen, Jamal Zweit, & Heinz Zwierzina. (2005). Phase I investigation of recombinant anti-human vascular endothelial growth factor antibody in patients with advanced cancer. European Journal of Cancer, 41, 555–563. https://doi.org/10.1016/j.ejca.2004.11.021

Chicago

Leif Håkansson, Meina Tang, Linda Wauk, C Mulatero, Malcolm R Ranson, John Wagstaff, Sandrine Marreaud, et al. 2005. “Phase I Investigation of Recombinant Anti-Human Vascular Endothelial Growth Factor Antibody in Patients with Advanced Cancer.” European Journal of Cancer 41 (March): 555–63. doi:10.1016/j.ejca.2004.11.021.